符合检索条件的记录共4条
共 1 页 当前第 1 页　　返回检索页

1	药品名称	DELALUTIN
	申请号	010347	产品号	002
	活性成分	HYDROXYPROGESTERONE CAPROATE	市场状态	停止上市
	剂型或给药途径	INJECTABLE;INJECTION	规格	250MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
	治疗等效代码		参比药物	否
	批准日期	Approved Prior to Jan 1, 1982	申请机构	BRISTOL MYERS SQUIBB
2	药品名称	DELALUTIN
	申请号	010347	产品号	004
	活性成分	HYDROXYPROGESTERONE CAPROATE	市场状态	停止上市
	剂型或给药途径	INJECTABLE;INJECTION	规格	125MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
	治疗等效代码		参比药物	否
	批准日期	Approved Prior to Jan 1, 1982	申请机构	BRISTOL MYERS SQUIBB
3	药品名称	DELALUTIN
	申请号	016911	产品号	001
	活性成分	HYDROXYPROGESTERONE CAPROATE	市场状态	停止上市
	剂型或给药途径	INJECTABLE;INJECTION	规格	125MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
	治疗等效代码		参比药物	否
	批准日期	Approved Prior to Jan 1, 1982	申请机构	BRISTOL MYERS SQUIBB
4	药品名称	DELALUTIN
	申请号	016911	产品号	002
	活性成分	HYDROXYPROGESTERONE CAPROATE	市场状态	停止上市
	剂型或给药途径	INJECTABLE;INJECTION	规格	250MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
	治疗等效代码		参比药物	否
	批准日期	Approved Prior to Jan 1, 1982	申请机构	BRISTOL MYERS SQUIBB

©2006-2025 DrugFuture->U.S. FDA Drugs Database